Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / SPON ADS NEW
-
Total 13F shares
-
2,928,684
-
Share change
-
-514,545
-
Total reported value
-
$1,792,461
-
Put/Call ratio
-
2.3%
-
Price per share
-
$0.62
-
Number of holders
-
18
-
Value change
-
-$233,685
-
Number of buys
-
6
-
Number of sells
-
12
Institutional Holders of ASLAN PHARMACEUTICALS LTD - SPON ADS NEW (ASLN) as of Q1 2024
As of 31 Mar 2024,
ASLAN PHARMACEUTICALS LTD - SPON ADS NEW (ASLN) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,928,684 shares.
The largest 10 holders included
BVF INC/IL, Velan Capital Investment Management LP, Shay Capital LLC, Sio Capital Management, LLC, Schonfeld Strategic Advisors LLC, RENAISSANCE TECHNOLOGIES LLC, CITADEL ADVISORS LLC, ADAR1 Capital Management, LLC, FNY Investment Advisers, LLC, and MILLENNIUM MANAGEMENT LLC.
This page lists
18
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.